Delivery Order SPE2DB25D3012-SPE2DB25FWZEQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,127.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on April 21, 2025, with an ultimate completion date of April 22, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $81,786.40. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 24, 2025, with a ceiling value of $5,119.23 and an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed from the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $6,155.89. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's significantly larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,721.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $9,966.32. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,794.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) with a completion date of July 30, 2025. This firm fixed-price delivery order, awarded on July 29, 2025, represents a non-set-aside competitive award with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,540.20 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZEQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count units) at a ceiling value of $49,619.13. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a competitive award with no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement needs across military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical requirements on a competitively awarded basis, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Jardiance, a diabetes medication, exemplifies the company's role in supporting the Defense Health Agency and broader military healthcare operations through flexible and scalable contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.6k | 8/13/25 |